Search Login Register

insulin aspart (NovoLog) Summary

Description: Insulin aspart in a 30/70 premixed formulation with basal insulin

Also Known As: NovoLog; NovoRapid; B28-Asp-insulin; B28Asp; BIAsp 30 Show All >>

Networked: 206 relevant articles (37 outcomes, 80 trials/studies) for this Drug

Key Diseases for which insulin aspart is Relevant

  1. Type 2 Diabetes Mellitus (MODY) : 12 outcomes 41 studies in 60 results
  2. Hypoglycemia (Reactive Hypoglycemia) : 10 outcomes 15 studies in 43 results
  3. Type 1 Diabetes Mellitus (Autoimmune Diabetes) : 5 outcomes 10 studies in 22 results
  4. Weight Gain : 3 outcomes 1 study in 16 results
  5. Body Weight (Weight, Body) : 2 outcomes 4 studies in 19 results
Show All >>

Drugs Related to insulin aspart

  1. Insulin (Novolin)
  2. insulin LISPRO (Humalog)
  3. insulin aspart (NovoLog)
  4. Glucose (Dextrose)
  5. glargine (insulin glargine)
  6. basal insulin
  7. NPH Insulin
  8. mitiglinide
  9. insulin detemir (Levemir)
  10. Metformin (Glucophage)
Show All >>

Therapies Related to insulin aspart

  1. Subcutaneous Infusions
  2. Stents
  3. Therapeutics
  4. Injections
  5. Subcutaneous Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.